相关实验视频
Updated: Jan 23, 2026

10:18
Agrobacterium-Mediated Virus-Induced Gene Silencing Assay In Cotton
Published on: August 20, 2011
24.9K
AAV-DJ介导的MYOC沉默作为一种基因治疗方法,用于肌林相关的玻璃眼
Yue Wan1, Xiangxiang Liu1, Xuejing Yan2
1Department of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Investigative ophthalmology & visual science
|January 22, 2026
概括
使用腺相关病毒血清型DJ (AAV-DJ) 载体进行基因疗法以使MYOC沉默,显示出它对治疗青光眼的前景. 这种方法减少了MYOC相关的玻璃眼的小鼠模型中的病理标志物,并保留了视力.
科学领域:
- 眼科医生 眼科 眼科
- 基因治疗 基因治疗
- 分子生物学分子生物学
背景情况:
- 玻璃眼是导致不可逆转失明的主要原因.
- 在MYOC基因的突变是主要的开角青光眼 (POAG) 的重要原因.
- 肌素在状眼网 (TM) 中的积累有助于眼内压力升高 (IOP).
研究的目的:
- 为了评估腺相关病毒血清型DJ (AAV-DJ) 载体提供MYOC向的短毛针RNA (shMYOC) 治疗MYOC相关的玻璃眼的治疗疗效.
- 评估MYOC沉默对MYOCP370L转基因小鼠模型 (Tg-MYOCP370L) 青光斑病理的影响.
主要方法:
- 携带shMYOC的AAV-DJ载体被通过Tg-MYOCP370L小鼠的静脉内注射给药.
- 评估包括肌素水平,内网膜 (ER) 压力标志物,IOP,水性幽默外流设施,视网膜质细胞 (RGC) 存活率和视觉功能.
- 利用AAV-DJ的转导效率和TM热带性进行了针对性基因传递.
主要成果:
- 在TM细胞中,AAV-DJ-shMYOC显著降低了肌素积累和ER压力.
- 治疗防止了年龄相关的内压升高,并保持了水性幽默流出设施.
- 在接受Tg-MYOCP370L治疗的年轻和老年小鼠中,RGC生存率和视觉功能保持不变.
结论:
- 在AAV-DJ介导的MYOC沉默有效地缓解了小鼠模型中的眼光斑病理.
- 这种基因治疗方法有可能用于治疗MYOC相关的玻璃眼.
- 有针对性的MYOC淘汰为特定形式的玻璃眼提供了一个有前途的治疗策略.
相关概念视频
Gene Therapy
27.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.4K
Glaucoma: Overview
1.3K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.3K
Organization of Genes
73.2K
Overview
73.2K
Open Angle Glaucoma: Treatment
969
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
969
Angle Closure Glaucoma: Treatment
1.2K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.2K
Receptor-mediated Endocytosis
110.6K
Overview
110.6K

